| 000 | 00882 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250516075403.0 | ||
| 264 | 0 | _c20120329 | |
| 008 | 201203s 0 0 eng d | ||
| 022 | _a1546-170X | ||
| 024 | 7 |
_a10.1038/nm0212-183 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDolgin, Elie | |
| 245 | 0 | 0 |
_aWith bated breath, companies await approval for inhalable drugs. _h[electronic resource] |
| 260 |
_bNature medicine _cFeb 2012 |
||
| 300 |
_a183 p. _bdigital |
||
| 500 | _aPublication Type: News | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 | _aDrug Approval |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Diseases _xdrug therapy |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 773 | 0 |
_tNature medicine _gvol. 18 _gno. 2 _gp. 183 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/nm0212-183 _zAvailable from publisher's website |
| 999 |
_c21522980 _d21522980 |
||